All Respiratory articles
-
VideoGOLD COPD 2021 summary tour
This Guidelines summary tour highlights the new recommendations in the GOLD 2021 report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
-
News
NHS prepares for rise in child respiratory infections
Respiratory infections have begun to rise in young children following low infection levels in response to COVID-19 restrictions
-
Information
Clinical focus: asthma
Each month, Guidelines puts one clinical area under the spotlight. This month, we focus on asthma, bringing you discussions on innovation and management, and what we can learn from GINA, NICE, and BTS/SIGN on diagnosis, from Dr Omar Usmani and Dr Stephen Holmes at Guidelines Live 2020.
-
Information
COVID-19 hub for primary care
The Guidelines team has produced this directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies
-
Information
COVID-19 hub for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
Independent professional body guideline
GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
-
News
GINA updates global strategy for asthma management and prevention
The update to GINA’s 2021 report contains updated treatment recommendations, and new advice about COVID-19 and asthma
-
NICE guideline
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View prescribing information
PC-GB-103143 November 2020 -
Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View prescribing information
PC-GB-103141 November 2020 -
Independent professional body guideline
GOLD COPD 2021 strategy
A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD
-
Hosted content
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0 -
News
GOLD COPD report 2021 published
GOLD has published its annual report on chronic obstructive lung disease, used worldwide by healthcare experts
-
Hosted content
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013 -
Hosted content
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012 -
Hosted content
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011 -
Prescribing summary card
DuoResp® Spiromax® (budesonide/formoterol)
This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020 -
NICE guideline
COVID-19 rapid guideline on cystic fibrosis
The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.
-
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
